RAND Europe has been asked to support the on-going Innovative Medicines and Medical Technologies Review through conducting a study to examine international examples of accelerating the use of drugs, devices and diagnostics.
Innovation and Technology Policy: Focus on Innovation Policy and Regulation
Innovation, unlike invention, is the creation of new — or the reconfiguration of existing — products and processes, and almost always involves numerous players. Increasingly, innovation emerges in the context of complex constellations of public and private organisations, institutions, markets and regulation, all of which can impact on its direction and rate of change. It is this dynamic and systemic interplay of complex interventions that informs RAND Europe's understanding of innovation. This interplay also defines our approach to understanding how innovation and technology policy can best serve the needs of different kinds of organisations, economies and societies.
Our work cuts across public and private sectors. Whether it's finding an evidence base for R&D models in pharmaceuticals or identifying emerging e-health business models, we apply our own innovative thinking to new challenges. Our focus ranges from knowledge exchange and translational research in food and agriculture to regulatory issues regarding innovation and finally, to perceptions of security and privacy issues related to ICTs.